New chemo combo offers hope for rare sarcoma patients
NCT ID NCT04605770
First seen Apr 30, 2026 · Last updated May 09, 2026 · Updated 3 times
Summary
This study tests a combination of two chemotherapy drugs, pemetrexed and cisplatin, in people with advanced or recurrent soft tissue sarcoma that has not responded to prior treatments. The goal is to see if this combination can slow tumor growth and improve outcomes. About 164 adults with specific sarcoma subtypes will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA,SOFT TISSUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Severance Hospital
RECRUITINGSeoul, 03722, South Korea
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.